ITEAHR agonist CAS# 448906-42-1 |
- CGS 21680
Catalog No.:BCC1475
CAS No.:120225-54-9
- Preladenant
Catalog No.:BCC1868
CAS No.:377727-87-2
- Pentostatin
Catalog No.:BCC1845
CAS No.:53910-25-1
- Tozadenant
Catalog No.:BCC2011
CAS No.:870070-55-6
- LUF6000
Catalog No.:BCC1710
CAS No.:890087-21-5
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 448906-42-1 | SDF | Download SDF |
PubChem ID | 4668801 | Appearance | Powder |
Formula | C14H10N2O3S | M.Wt | 286.3 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | DMSO : ≥ 41 mg/mL (143.20 mM) H2O : < 0.1 mg/mL (insoluble) *"≥" means soluble, but saturation unknown. | ||
Chemical Name | methyl 2-(1H-indole-3-carbonyl)-1,3-thiazole-4-carboxylate | ||
SMILES | COC(=O)C1=CSC(=N1)C(=O)C2=CNC3=CC=CC=C32 | ||
Standard InChIKey | KDDXOGDIPZSCTM-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C14H10N2O3S/c1-19-14(18)11-7-20-13(16-11)12(17)9-6-15-10-5-3-2-4-8(9)10/h2-7,15H,1H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Endogenous aryl hydrocarbon receptor (AhR) agonist (Ki = 3 nM). Decreases Oct4 levels in U87 glioblastoma cells. Induces stem-like cancer cell differentiation in U87 tumor spheres and inhibits ovarian cancer cell proliferation in vitro. Suppresses tumor growth in U87 and OVCAR-3 cell xenografts in mice. Also inhibits TGF-β-induced human myofibroblast differentiation. |
ITE Dilution Calculator
ITE Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.4928 mL | 17.4642 mL | 34.9284 mL | 69.8568 mL | 87.321 mL |
5 mM | 0.6986 mL | 3.4928 mL | 6.9857 mL | 13.9714 mL | 17.4642 mL |
10 mM | 0.3493 mL | 1.7464 mL | 3.4928 mL | 6.9857 mL | 8.7321 mL |
50 mM | 0.0699 mL | 0.3493 mL | 0.6986 mL | 1.3971 mL | 1.7464 mL |
100 mM | 0.0349 mL | 0.1746 mL | 0.3493 mL | 0.6986 mL | 0.8732 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
2-(1′H-indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester (ITE) is a nontoxic immunosuppressive endogenous aryl hydrocarbon receptor (AhR) ligand [1] [2]. Its EC50 identified via yeast AhR assay is 7.8×10−10 mol/l [3].
AhR is a transcription factor mediating toxic effects of environmental pollutants such as 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD), it is activated by ligand [2].
ITE inhibited TGFβ1-induced myofibroblast differentiation in TGFβ1-challenged cultures of primary human fibroblasts from several distinct tissue types. In primary human orbital fibroblasts, ITE inhibited TGFβ1-induced nuclear translocation of Smad2/3/4 and its subsequent binding to SBE, but it did not inhibit TGFβ1-induced phosphorylation of Smad2/3, Erk1/2, or Akt [4], it inhibited TGFβ1 (1 ng/mL)-induced α-smooth muscle actin (α-SMA) expression, extracellular matrix production [5]. The inhibition of ITE to TGFβ1-induced myofibroblast differentiation in primary human fibroblasts is AhR independent [5].
In Sprague-Dawley rats maintained under a 12 h light/12 h dark cycle and given free access to a solid diet and distilled water, ITE at 1.6 and 8.0 mg/kg bw, significantly increased the CYP1A1 mRNA levels by 5.59 and 68.55 fold, respectively. It indicated that ITE activated AhR activation in placentas. 8.0 mg/kg bw ITE elevated the level of HIF-1a mRNA, induced the levels of VEGF-A, VEGF-B and PIGF mRNA in a dose-dependent manner [6].
References:
[1]. Lindsey F. Nugent, Guangpu Shi, Barbara P. Vistica, et al. ITE, A Novel Endogenous Nontoxic Aryl Hydrocarbon Receptor Ligand, Efficiently Suppresses EAU and T-Cell–Mediated Immunity. Invest Ophthalmol Vis Sci., 2013, 54(12):7463-7469.
[2]. Jaishree Bankoti, Ben Rase, Tom Simones, et al. Functional and phenotypic effects of AhR activation in inflammatory dendritic cells. Toxicol Appl Pharmacol., 2010, 246(1-2):18-28.
[3]. S. Medjakovic and A. Jungbauer. Red clover isoflavones biochanin A and formononetin are potent ligands of the human aryl hydrocarbon receptor. Journal of Steroid Biochemistry & Molecular Biology, 2008, 108:171-177.
[4]. Geniece M. Lehmann, Xia Xi, Ajit A. Kulkarni, et al. The Aryl Hydrocarbon Receptor Ligand ITE Inhibits TGFβ1-Induced Human Myofibroblast Differentiation. American Journal of Pathology, 2011, 178(4):1556–1567.
[5]. Geniece M. Lehmann, Xia Xi, Ajit A. Kulkarni, et al. The Aryl Hydrocarbon Receptor Ligand ITE Inhibits TGF1-Induced Human Myofibroblast Differentiation. The American Journal of Pathology, 2011, 178(4):1556-1567.
[6]. Yanming Wu, Xiao Chen, Qian Zhou, et al. ITE and TCDD Differentially Regulate the Vascular Remodeling of Rat Placenta via the Activation of AhR. PLoS ONE, 2014, 9(1): e86549.
- 3-(4-Methoxyphenyl)-1-(pyrrol-1-yl)propan-1-one
Catalog No.:BCN1440
CAS No.:448905-82-6
- WY 45233 succinate
Catalog No.:BCC6125
CAS No.:448904-47-0
- NS 1643
Catalog No.:BCC7552
CAS No.:448895-37-2
- Betulonic acid
Catalog No.:BCN5500
CAS No.:4481-62-3
- Sulforaphane
Catalog No.:BCN2349
CAS No.:4478-93-7
- Ruixianglangdusu B
Catalog No.:BCN6869
CAS No.:447454-49-1
- RLLFT-NH2
Catalog No.:BCC3954
CAS No.:447408-68-6
- Angiotensin II human
Catalog No.:BCC4087
CAS No.:4474-91-3
- RepSox
Catalog No.:BCC1887
CAS No.:446859-33-2
- 4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one
Catalog No.:BCC8646
CAS No.:446292-10-0
- YM 230888
Catalog No.:BCC5956
CAS No.:446257-23-4
- 2,4,5-Trimethoxybenzaldehyde
Catalog No.:BCN5498
CAS No.:4460-86-0
- Quercetin 3-O-[2-O-(6-O-E-feruloyl)-beta-D-glucopyranosyl]-beta-D-galactopyranoside
Catalog No.:BCN1439
CAS No.:448948-20-7
- 4',4''-Dihydroxyanigorootin
Catalog No.:BCN7153
CAS No.:448949-11-9
- Rubinaphthin A
Catalog No.:BCN3511
CAS No.:448962-05-8
- Indaconitine
Catalog No.:BCN6259
CAS No.:4491-19-4
- 9-O-Acetyl-fargesol
Catalog No.:BCN8216
CAS No.:449172-61-6
- VPC 23019
Catalog No.:BCC7883
CAS No.:449173-19-7
- (+)-S-Myricanol glucoside
Catalog No.:BCN5501
CAS No.:449729-89-9
- Specneuzhenide
Catalog No.:BCC9151
CAS No.:449733-84-0
- FAK Inhibitor 14
Catalog No.:BCC7683
CAS No.:4506-66-5
- Homogentisic acid
Catalog No.:BCN3889
CAS No.:451-13-8
- H-Met-NH2
Catalog No.:BCC2994
CAS No.:4510-08-1
- H-Aib-OtBu.HCl
Catalog No.:BCC3208
CAS No.:4512-32-7
Genome-wide transcriptional profiling of human glioblastoma cells in response to ITE treatment.[Pubmed:26484269]
Genom Data. 2015 Jun 30;5:281-3.
A ligand-activated transcription factor aryl hydrocarbon receptor (AhR) is recently revealed to play a key role in embryogenesis and tumorigenesis (Feng et al. [1], Safe et al. [2]) and 2-(1'H-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester (ITE) (Song et al. [3]) is an endogenous AhR ligand that possesses anti-tumor activity. In order to gain insights into how ITE acts via the AhR in embryogenesis and tumorigenesis, we analyzed the genome-wide transcriptional profiles of the following three groups of cells: the human glioblastoma U87 parental cells, U87 tumor sphere cells treated with vehicle (DMSO) and U87 tumor sphere cells treated with ITE. Here, we provide the details of the sample gathering strategy and show the quality controls and the analyses associated with our gene array data deposITEd into the Gene Expression Omnibus (GEO) under the accession code of GSE67986.
A tryptophan derivative, ITE, enhances liver cell metabolic functions in vitro.[Pubmed:27959388]
Int J Mol Med. 2017 Jan;39(1):101-112.
Cell encapsulation provides a three-dimensional support by incorporating isolated cells into microcapsules with the goal of simultaneously maintaining cell survival and function, as well as providing active transport for a bioreactor in vitro similarly to that observed in vivo. However, the biotra-nsformation and metabolic functions of the encapsulated cells are not satisfactory for clinical applications. For this purpose, in this study, hepatoma-derived Huh7 cells/C3A cells were treated with 2-(1'H-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester (ITE), an endogenous non-toxic ligand for aryl hydrocarbon receptor, in monolayer cultures and on microspheres. The mRNA and protein levels, as well as the metabolic activities of drug metabolizing enzymes, albumin secretion and urea synthesis were determined. When the Huh7 and C3A cells cultured in a monolayer on twodimensional surfaces, ITE enhanced the protein levels and the metabolic activities of the major cytochrome P450 (CYP450) enzymes, CYP1A1, CYP1A2, CYP3A4 and CYP1B1, and slightly increased albumin secretion and urea synthesis. Moreover, when cultured on microspheres, ITE also substantially increased the protein levels and metabolic activities of CYP1A1, CYP1A2, CYP3A4 and CYP1B1 in both liver cell lines. On the whole, our findings indicate that ITE enhances the enzymatic activities of major CYP450 enzymes and the metabolic functions of liver cells cultured in monolayer or on microspheres, indicating that it may be utilized to improve the functions of hepatocytes. Thus, it may be used in the future for the treatment of liver diseases.
ITE and TCDD differentially regulate the vascular remodeling of rat placenta via the activation of AhR.[Pubmed:24475139]
PLoS One. 2014 Jan 24;9(1):e86549.
Vascular remodeling in the placenta is essential for normal fetal development. The previous studies have demonstrated that in utero exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD, an environmental toxicant) induces the intrauterine fetal death in many species via the activation of aryl hydrocarbon receptor (AhR). In the current study, we compared the effects of 2-(1'H-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester (ITE) and TCDD on the vascular remodeling of rat placentas. Pregnant rats on gestational day (GD) 15 were randomly assigned into 5 groups, and were exposed to a single dose of 1.6 and 8.0 mg/kg body weight (bw) ITE, 1.6 and 8.0 microg/kg bw TCDD, or an equivalent volume of the vehicle, respectively. The dams were sacrificed on GD20 and the placental tissues were gathered. The intrauterine fetal death was observed only in 8.0 microg/kg bw TCDD-exposed group and no significant difference was seen in either the placental weight or the fetal weight among all these groups. The immunohistochemical and histological analyses revealed that as compared with the vehicle-control, TCDD, but not ITE, suppressed the placental vascular remodeling, including reduced the ratio of the placental labyrinth zone to the basal zone thickness (at least 0.71 fold of control), inhibITEd the maternal sinusoids dilation and thickened the trophoblastic septa. However, no marked difference was observed in the density of fetal capillaries in the labyrinth zone among these groups, although significant differences were detected in the expression of angiogenic growth factors between ITE and TCDD-exposed groups, especially Angiopoietin-2 (Ang-2), Endoglin, Interferon-gamma (IFN-gamma) and placenta growth factor (PIGF). These results suggest ITE and TCDD differentially regulate the vascular remodeling of rat placentas, as well as the expression of angiogenic factors and their receptors, which in turn may alter the blood flow in the late gestation and partially resulted in intrauterine fetal death.